
Bioindustry: A Description of California's
Bioindustry and Summary of the Public Issues Affecting Its
Development
By Gus A. Koehler, PhD.
Prepared at the Request of Assemblyman John
Vasconcellos
April 1996
Biotechnology, the application of engineering concepts to
biological processes, is relatively new, rapidly growing, and
profoundly important. The field is sprawling and complex. California,
especially northern California, has been a world leader in
biotechnology and bioindustry since modern biotechnology was
"invented" in the San Francisco Bay Area in 1973. One of the key
scientific breakthroughs that made the field possible, gene splicing,
depends on technology developed by professors at the University of
California at San Francisco and Stanford University. The California
State Assembly has been involved in bioindustry public policy making
for over 10 years.
- DIGEST
- An Overview of Biotechnology
and Bioindustry
- Background
- Basic Classification of
Bioindustry firms
- Human Health-Related
Products
- Bioindustry Animal and
Plant Products
- Animal
Products
- Introduction
of Genetically Engineered Products into Animals to
Improve Their Economic Value
- Transgenic
Animals
- "Gene Pharming"
- Organ
Transplants
- Plant Biotechnology
- Herbicide-Resistant
Plants
- Virus-Resistant
Plants
- Food Processing
- Research on Environmental
Cleanup and New Energy Sources
- Energy
- Bioremediation
- Links with
Microelectronics and Nanotechnology
- Research Priorities and
the Market Place
- Agribusiness Industry
Organization and Biotechnology Research Priorities
- Bioindustry in the U.S., California,
and the World
- National
Bioindustry
- California's
Bioindustry
- Employment
- Sales, Revenues and
Markets
- Bioindustry Suppliers and
Construction
- Factors Contributing to
Regional Development of Biotechnology in California
- International Competition
for Biotechnology Markets
- Belgium
- Germany
- Indonesia
- Netherlands
- Singapore
- United Kingdom
- Regulation of Biotechnology
- Federal
Regulations
- State Approaches To
Regulation
- Current California
Bioindustry Regulation
- Federal, State, and Local
Government Regulations often Overlap
- Owning or Patenting
Animals, Plants, and Human Biological Materials
- Human
Biological Material Property Rights
- Public Funding and
Intellectual Property Rights
- Professional Conflicts
of Interest
- Food Product Labeling And
Safety
- Ethical Issues and Risk Assessment in
Biotechnology
- Creation of New
Genomes and Genetically Engineered Biologically Active
Substances
- Ethical Debate On
Patenting Life
- Organ Transplants And
Embryological Tissue
- Animal to
Human Organ Transplants
- Bioethics and Human
Diagnostics
- Field Testing and Growing
Genetically Engineered Crops
- Reframing Bioethical
Issues for Public Policy
- Business Needs of
Biotechnology
- Workforce and
Training
- Financing Bioindustry
- Survival Index for
Biotechnology Companies
- Private
Sources of Capital Investment and Financing
- International
Investment
- Joint Ventures and
Alliances
- Government Sources of
Investment and Financing
- State
Government Funding
- Government-Supported Biotechnology
Centers
- Research and Development
Funding
- Funding
University Research
- Private Industry
Research Funding
- Product Development
- Bioindustry
Manufacturing
- Scale-up from
Basic Discovery to Production
- Manufacturing Facility
Construction
- Water
- Hazardous Materials
Disposal and Spill Cleanup
- Air Pollution
- Liability Issues and
the Availability of Biomaterials
- Public Policy Options
- Critical
Factors
- Is There a Role for
Government?
- Research
- Biotechnology Ethical
Issues
- Economic Development
- California
Biotechnology Development Strategy
- Strategy Options
- Economic Policy For A
Global Biotechnology Industry
- Bioindustry Networks
- Product Development
- Health Care
- Manufacturing
- Regulations
- Financing
- Workforce Training
- Selected Bibliography
- General
Sources
- State of
California/University of California Documents
- Federal Government
Documents
- Bio/Technology Magazine
Articles
- Other Periodical
Articles
- Appendix: Biotech
Organizations
Next Chapter: Digest